ERC Starting Grant · 2021
Computationally and experimentallY BioEngineeRing the next generation of Growing HEARTs
Congenital Heart Disease (CHD) results when the heart abnormally develops before birth. With diminished cardiac function, the heart fails to supply the required oxygenated blood to the body, causing a cascade of failures at different scales that prevent the newborn from growing normally. Even with improved surgical and medical treatments, CHD remains a lifelong risk factor for many diseases. An emerging application in cardiac tissue engineering is the 3D bioprinting of human hearts, or their parts, for clinical transplantation, with CHD representing a potential therapeutic target. Whereas the fabrication of bioartificial hearts is currently feasible, there remain significant scientific and…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.